Randomized, Double-blind, Active-controlled Study Evaluating the Safety and Immunogenicity of Three Vaccination Schedules and Two Dose Levels of AV7909 Vaccine for Anthrax Post-exposure Prophylaxis in Healthy Adults

AV7909 vaccine being developed for post-exposure prophylaxis of anthrax disease may require fewer vaccinations and reduced amount of antigen to achieve an accelerated immune response over BioThrax(®) (Anthrax Vaccine Adsorbed). A phase 2, randomized, double-blind, BioThrax vacccine-controlled study...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccine
Main Authors: Hopkins, Robert J., Kalsi, Gurdyal, Montalvo-Lugo, Victor M., Sharma, Mona, Wu, Yukun, Muse, Derek D., Sheldon, Eric.A., Hampel, Frank C., Lemiale, Laurence
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4839983/
https://ncbi.nlm.nih.gov/pubmed/26979136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2016.03.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados